Ab­b­Vie, Eli Lil­ly quit UK's vol­un­tary drug pric­ing agree­ment, send­ing 'warn­ing sig­nal' to UK gov­ern­ment

Ma­jor phar­mas Eli Lil­ly and Ab­b­Vie have ex­it­ed the UK Na­tion­al Health Ser­vice’s vol­un­tary med­i­cine pric­ing agree­ment, cit­ing un­jus­ti­fi­able rev­enue claw­backs, the As­so­ci­a­tion of the British Phar­ma­ceu­ti­cal In­dus­try an­nounced Mon­day.

In De­cem­ber, the UK gov­ern­ment said com­pa­nies with brand­ed med­i­cines un­der the vol­un­tary agree­ment will have to re­turn al­most £3.3 bil­lion in sales rev­enue to the gov­ern­ment, a sig­nif­i­cant jump from £0.6 bil­lion in 2021 and £1.8 bil­lion in 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER